COMPANY INFO
Octagos, Inc. was founded in 2020 by Dr. Shanti Bansal, a practicing cardiac electrophysiologist. The company has approximately 111 employees and is headquartered in Houston, Texas, operating in the Medical Records Systems and Hospitals and Health Care industry. Octagos develops advanced cardiac remote monitoring software that consolidates device transmissions and patient data in real time, using artificial intelligence to interpret complex cardiac data. Their platform integrates with electronic medical records (EMR) systems to help healthcare professionals efficiently manage high volumes of patient data and prioritize urgent cases, improving patient outcomes and clinical workflow efficiency.
Octagos, Inc. is an innovative health tech company founded in 2020 by Dr. Shanti Bansal and headquartered in Houston, Texas. With approximately 111 employees, Octagos, Inc. specializes in advanced cardiac remote monitoring software leveraging artificial intelligence to interpret and consolidate complex cardiac data. The company's platform integrates with electronic medical records (EMR) systems, helping healthcare providers efficiently manage and prioritize large volumes of patient data, ultimately improving patient outcomes and streamlining clinical workflows. Operating within the Medical Records Systems and broader Hospitals and Health Care industry, Octagos, Inc. is committed to transforming the delivery of cardiac data management for healthcare professionals.
Octagos, Inc. has rapidly built an impressive funding history, underscoring its position in digital health innovation. To date, Octagos, Inc. funding totals $51.9 million across two primary funding rounds. The first, a Series A round in 2022, primed the company for product development and its initial go-to-market strategy. In 2024, Octagos, Inc. successfully closed a $43 million Series B round, fueling its strategic market expansion and scaling operational capabilities. The company’s funding strategy highlights a strong trajectory, leveraging reputable venture capital partners and focusing capital towards technological advancement and growth in the healthcare sector.
This latest Series B round will enable Octagos, Inc. to accelerate its market expansion and ramp up operational scaling. The investment is geared towards broadening the company’s reach and refining its innovative cardiac monitoring solutions.
The Series A round provided critical capital for product development and the company's initial market entry. Funds were allocated to advance the AI-powered cardiac remote monitoring platform and integrate with EMR systems.
Morgan Stanley Expansion Capital, a well-regarded growth-focused venture capital investor, played a key role in Octagos, Inc.'s funding journey, leading the Series B round. Their involvement underscores confidence in Octagos, Inc. investment potential and supports the company’s growth and expansion objectives.
Mucker Capital, a prominent early-stage venture capital firm, co-led the Series B funding round for Octagos, Inc. Mucker Capital’s backing provides both capital support and strategic guidance, helping power the company’s continued innovation and expansion within healthcare technology.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Octagos, Inc. funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.